Online Database of Chemicals from Around the World

Bufexamac
[CAS# 2438-72-4]

List of Suppliers
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Minakem S.A.S. France Inquire  
+33 (3) 2064-6830
contact@minakem.com
Chemical manufacturer
chemBlink standard supplier since 2009
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Hengshui Haoye Chemical Co., Ltd. China Inquire  
+86 (318) 210-2300
+86 18632882519
firmcn@gmail.com
Chemical distributor
chemBlink standard supplier since 2011
Selleck Chemicals LLC USA Inquire  
+1 (713) 535-9129
info@selleckchem.com
Chemical manufacturer
chemBlink standard supplier since 2014
Leap Chem Co., Ltd. China Inquire  
+86 (852) 3060-6658
market19@leapchem.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2015
Beri Pharma Co., Ltd. China Inquire  
+86 19500796935
elena@zhberi.com
Skype Chat
WeChat: 19500796925
WhatsApp: +8619500796925
Chemical manufacturer since 2015
chemBlink standard supplier since 2024
Santa Cruz Biotechnology, Inc. USA Inquire  
+1 (831) 457-3800
scbt@scbt.com
Chemical manufacturer
Complete supplier list of Bufexamac
Identification
Classification API >> Antipyretic analgesics >> Non-steroidal anti-inflammatory drugs
Name Bufexamac
Synonyms 4-Butoxy-N-hydroxybenzeneacetamide; 2-(p-Butoxyphenyl)acetohydroxamic acid
Molecular Structure CAS # 2438-72-4, Bufexamac, 4-Butoxy-N-hydroxybenzeneacetamide, 2-(p-Butoxyphenyl)acetohydroxamic acid
Molecular Formula C12H17NO3
Molecular Weight 223.27
CAS Registry Number 2438-72-4
EC Number 219-451-1
SMILES CCCCOC1=CC=C(C=C1)CC(=O)NO
Properties
Solubility 553.5 mg/L (25 ºC water)
Density 1.1±0.1 g/cm3, Calc.*
Index of Refraction 1.530, Calc.*
Melting point 161.09 ºC
Boiling Point 416.39 ºC
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H317    Details
Precautionary Statements P261-P264-P270-P272-P280-P301+P317-P302+P352-P321-P330-P333+P317-P362+P364-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin sensitizationSkin Sens.1BH317
SDS Available
up Discovory and Applicatios
Developed in the mid-20th century, bufexamac emerged as a result of systematic exploration into novel compounds with anti-inflammatory properties. Its synthesis involved intricate chemical modifications and optimization to enhance its efficacy and safety profile, leading to the creation of a potent therapeutic agent with diverse applications.

Bufexamac is widely used as a topical anti-inflammatory agent for the treatment of various inflammatory skin conditions, including eczema, dermatitis, and pruritus. Its mechanism of action involves inhibiting the synthesis of inflammatory mediators such as prostaglandins and leukotrienes, thereby reducing inflammation, redness, and itching associated with these dermatological disorders. Bufexamac's anti-inflammatory properties make it effective in the management of hemorrhoids, a common condition characterized by swollen and inflamed blood vessels in the rectal area. Topical formulations containing bufexamac provide relief from pain, swelling, and discomfort associated with hemorrhoids, promoting healing and alleviating symptoms. Bufexamac-containing creams and ointments are often used to soothe and relieve sunburn symptoms, including pain, redness, and inflammation. Bufexamac accelerates wound healing by reducing inflammation and promoting tissue repair processes. Topical application of bufexamac to wounds and minor skin injuries aids in reducing swelling, preventing infection, and facilitating the formation of granulation tissue, leading to faster healing and reduced scarring. Bufexamac exhibits mild analgesic properties, offering relief from pain associated with inflammatory skin conditions, sunburn, and minor injuries. Its ability to alleviate pain complements its anti-inflammatory effects, providing comprehensive symptom relief for individuals experiencing discomfort due to various dermatological issues.
Market Analysis Reports
List of Reports Available for Bufexamac
Related Products
Budesonide EP Impurity B  Budesonide EP Impurity I  Budesonide Impurity 30  Budesonide Impurity M  Budesonide 1,4,14-Triene Triol Impurity  Budipine  Budralazine  Buergerinin B  Buergerinin G  Bufalin  Buflomedil  Buflomedil hydrochloride  Buflomedil pyridoxal phosphate  Buformin hydrochloride  Bufotaline  (±)-Bulbocapnine  Bulbocapnine hydrochloride  Bulbokapnin  Bullatantriol  Bullatine A